Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Manal F. Abdelmalek"'
Autor:
Alan W. Hemming, Giuseppi J. Morelli, Victor I. Machicao, Consuelo Soldevila-Pico, David R. Nelson, Titte R. Srinivas, Alan I. Reed, Manal F. Abdelmalek, Roberto J. Firpi
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 12(5)
The implementation of the model for end-stage liver disease (MELD) score decreased mortality of those awaiting liver transplantation (LT); however, the impact of the MELD allocation system on the risk of chronic renal disease after LT remains unknown
Autor:
Manal F. Abdelmalek, Victor I. Machicao, Giuseppe Morelli, Consuelo Soldevilla-Pico, Alan I. Reed, Roberto J. Firpi, David R. Nelson
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 12(2)
Adult to adult right hepatic lobe living donor liver transplantation (LDLT) accounts for 10% of all liver transplants performed in the United States. Although the overall morbidity and mortality to the donor is low, complications resulting in death a
Autor:
Alan I. Reed, Chen Liu, Roniel Cabrera, Roberto J. Firpi, Consuelo Soldevila-Pico, Haizhen Zhu, Manal F. Abdelmalek, Victor I. Machicao, Giuseppe Morelli, David R. Nelson
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 12(1)
Cyclosporine is an immunosuppressive agent widely used in the management of liver transplant recipients. Cyclosporine has been shown to have antiviral activities against HIV, herpes simplex, and vaccinia viruses. The aim of this study was to determin
Autor:
Manal F, Abdelmalek, Roberto J, Firpi, Consuelo, Soldevila-Pico, Alan I, Reed, Alan W, Hemming, Chen, Liu, James M, Crawford, Gary L, Davis, David R, Nelson
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 10(2)
Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but
Autor:
David D. Douglas, Nizar N. Zein, David H. Persing, Russell H. Wiesner, Tousif M. Pasha, Manal F. Abdelmalek
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 9(12)
Transmission of hepatitis B infection has been reported in liver transplant recipients whose donor livers were negative for hepatitis B surface antigen (HBsAg) and positive for antibody to hepatitis B core antigen (anti-HBc). These infections usually